#StimLabs
LightNews LightNews
ip-law.bsky.social
Georgia Federal Court Denies TRO and Motion to Dismiss in Trade Secrets Case
Georgia Federal Court Denies TRO and Motion to Dismiss in Trade Secrets Case
On March 27, 2025, in Stimlabs LLC v. Griffiths, the U.S. District Court for the Northern District of Georgia ordered a former executive, Sarah...
www.jdsupra.com
April 18, 2025 at 1:30 PM
longtail-news.bsky.social
Feed: "Medical Device Network"
By: gullapalli on Monday, November 3, 2025
StimLabs reports findings from dCHPM allograft study in wound care
StimLabs has reported findings from a multicentre trial of its fenestrated dehydrated complete human placental membrane (dCHPM) allograft.
www.medicaldevice-network.com
November 3, 2025 at 7:28 PM
newsen.bsky.social
StimLabs Unveils Architect: A Revolutionary Device for Advanced Wound Care Treatment#United_States#StimLabs#Wound_Care#Roswell#Architect_Fx
StimLabs Unveils Architect: A Revolutionary Device for Advanced Wound Care Treatment
StimLabs has launched Architect Fx, an advanced collagen matrix device aimed at improving wound care. Discover its innovative features.
third-news.com
March 3, 2026 at 4:37 PM
newsen.bsky.social
StimLabs® Achieves FDA Clearance for DermaForm™, a Key Wound Care Innovation#USA#StimLabs#Geistlich#Roswell#DermaForm
StimLabs® Achieves FDA Clearance for DermaForm™, a Key Wound Care Innovation
StimLabs announces FDA 510(k) clearance for DermaForm™, a collagen scaffold designed for effective wound care. This marks a significant advancement in regenerative medicine.
third-news.com
February 12, 2026 at 2:29 PM
newsen.bsky.social
StimLabs and Geistlich Join Forces for Innovative Wound Care Solution Launching in 2026#United_States#StimLabs#Geistlich#regenerative_medicine#Roswell
StimLabs and Geistlich Join Forces for Innovative Wound Care Solution Launching in 2026
StimLabs and Geistlich are enhancing their partnership to launch a cutting-edge wound care product in Q2 2026, promising advanced solutions in regenerative medicine.
third-news.com
January 12, 2026 at 3:23 PM
newsen.bsky.social
Stimlabs Launches Allacor P: A Breakthrough in Wound Management with FDA Approval#USA#StimLabs#Roswell#Wound_Management#Allacor_P
Stimlabs Launches Allacor P: A Breakthrough in Wound Management with FDA Approval
Stimlabs has introduced Allacor P, the first FDA-cleared umbilical cord-derived device for efficient wound care, enhancing treatment options for patients.
third-news.com
January 5, 2026 at 1:38 PM
newsen.bsky.social
StimLabs Secures FDA Clearance for Revolutionary Theracor™ Device from Umbilical Cord Tissues#USA#FDA_Clearance#StimLabs#Roswell#Theracor
StimLabs Secures FDA Clearance for Revolutionary Theracor™ Device from Umbilical Cord Tissues
StimLabs has achieved FDA 510(k) clearance for Theracor, the first umbilical cord-derived medical device sheet, enhancing wound care options.
third-news.com
December 29, 2025 at 1:47 PM
newsen.bsky.social
StimLabs Publishes New Study Highlighting Positive Effects of Relese in Chronic Wound Healing#USA#Roswell,_Georgia#StimLabs#Wound_Healing#Relese
StimLabs Publishes New Study Highlighting Positive Effects of Relese in Chronic Wound Healing
A recent study by StimLabs reveals the efficacy of Relese in treating chronic wounds. The findings support its use as an adjunct therapy, enhancing wound healing.
third-news.com
October 31, 2025 at 1:19 PM
newsen.bsky.social
StimLabs Achieves ISO 13485:2016 Certification Signifying Quality Leadership in Medical Device Industry#USA#StimLabs#Roswell#ISO_13485#Regenerative_Science
StimLabs Achieves ISO 13485:2016 Certification Signifying Quality Leadership in Medical Device Industry
StimLabs has proudly announced that it has received the ISO 13485:2016 certification, underscoring its commitment to quality and patient safety in regenerative science.
third-news.com
September 24, 2025 at 3:48 PM
newsen.bsky.social
StimLabs Secures Major Regenerative Biologics Contract with Vizient to Enhance Patient Care#United_States#StimLabs#Vizient#Roswell#Regenerative_Biologics
StimLabs Secures Major Regenerative Biologics Contract with Vizient to Enhance Patient Care
StimLabs announces its new national contract with Vizient, enhancing access for hospitals and improving patient care through innovative regenerative biologics.
third-news.com
August 4, 2025 at 1:33 PM
newsen.bsky.social
StimLabs Partners with Geistlich to Transform Wound Care Advances#USA#Roswell,_Georgia#StimLabs#Geistlich#Derma-Gide
StimLabs Partners with Geistlich to Transform Wound Care Advances
StimLabs has secured exclusive rights to distribute Geistlich's wound care products, which enhances healing solutions for patients and clinicians.
third-news.com
November 26, 2024 at 12:42 PM
susanleong.bsky.social
StimLabs Announces National Availability of Corplex P

www.viv-media.com/infozx-34591...
StimLabs Announces National Availability of Corplex P
www.viv-media.com
October 2, 2024 at 2:44 PM
dpsa.bsky.social
Former Stimlabs Exec Must Face Trade Secrets Claims
A former biomedical technology company executive must face claims that she absconded with thousands of internal files containing valuable product information in the days and weeks leading up to her ouster last year, a Georgia federal judge ruled.
www.law360.com
April 1, 2025 at 2:28 AM
remoteradar.bsky.social
#Remote work calling your name? 📞

Here is today's round-up.

🗺️ DevOps Engineer at CXT Software

🗺️ Senior Research Manager at DCG

🗺️ Default Manager at Hometap

🗺️ Senior ERP Developer at StimLabs

🗺️ Power BI Analyst at NRI North America
May 20, 2025 at 5:13 PM
l2plabs.bsky.social
Stimlabs® LLC Announces Launch of Allacor P™ - The first FDA 510(k) cleared human umbilical cord particulate device for wound management
ROSWELL, Ga., Jan. 5, 2026 /PRNewswire/ -- StimLabs®, a leading regenerative medicine company, announces the launch of Allacor P, the first medical device derived from human umbilical cord extracellular matrix (ECM). Allacor P was awarded an A Code in 2025, allowing StimLabs to launch in...
dlvr.it
January 5, 2026 at 1:30 PM
l2plabs.bsky.social
StimLabs® Announces FDA Clearance of Theracor™: The First Human Umbilical Cord-Derived Medical Device Sheet
ROSWELL, Ga., Dec. 29, 2025 /PRNewswire/ -- StimLabs announces that the U.S. Food & Drug Administration (FDA) has granted 510(k) clearance for Theracor, the first human umbilical cord-derived medical device to be offered in sheet form. This clearance marks another significant milestone...
dlvr.it
December 29, 2025 at 1:33 PM
l2plabs.bsky.social
StimLabs® Announces New Real-World Study Demonstrating Positive Outcomes Using Relese® in the Treatment of Chronic Wounds
ROSWELL, Ga., Oct. 31, 2025 /PRNewswire/ -- StimLabs, a leading regenerative science company, announces the publication of its multicenter, retrospective study evaluating the real-world use of Relese, a fenestrated dehydrated complete human placental membrane (dCHPM) allograft, as an...
dlvr.it
October 31, 2025 at 1:02 PM
l2plabs.bsky.social
StimLabs® Announces Exclusive Distribution Rights for Geistlich's Leading Wound Care Portfolio
New Partnership Expands StimLabs Product Offering to Include Medicare Covered Xenograft, Derma-Gide (Q4203) ROSWELL, Ga., Nov. 26, 2024 /PRNewswire/ -- StimLabs, a leading regenerative medicine company, announced that it has entered into an exclusive…
dlvr.it
November 26, 2024 at 12:33 PM